What is Mossman Associates?
Mossman Associates is a company dedicated to advancing therapeutic interventions through a unique blend of biofeedback, sound frequency healing, music therapy, and guided imagery. Their core offering, the Biosound Therapy System, is a sophisticated platform designed to enhance patient treatment experiences. Beyond this, the company also provides the NicCheck I urine nicotine test, an FDA-cleared and CLIA-waived diagnostic tool that offers a convenient solution for healthcare professionals in both clinical and broader professional settings. This dual focus positions Mossman Associates as a provider of advanced tools for healthcare practitioners seeking to improve patient outcomes and diagnostic capabilities.
How much funding has Mossman Associates raised?
Mossman Associates has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in Mossman Associates
PPP
Public-Private Partnership
What's next for Mossman Associates?
With its Series A/B growth stage financing, Mossman Associates is poised for strategic expansion. The recent capital injection is expected to accelerate the development and market penetration of its Biosound Therapy System and potentially broaden the reach of its diagnostic offerings. This investment underscores investor confidence in the company's innovative approach to healthcare solutions and its potential to capture significant market share in the therapeutic and diagnostic sectors. Future initiatives will likely focus on scaling operations, enhancing product development, and forging new strategic partnerships to solidify its position in the competitive healthcare landscape.
See full Mossman Associates company page
